2
Announcements
Trials
Browse
Landscape
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Breast
1
Conditions
Multiple Myeloma
250
Lymphoma
128
Leukemia, Myeloid, Acute
103
Lymphoma, Non-Hodgkin
98
Precursor Cell Lymphoblastic Leukemia-Lymphoma
93
Neoplasms, Plasma Cell
91
Myelodysplastic Syndromes
91
Leukemia
79
Hodgkin Disease
78
Lymphoma, Large B-Cell, Diffuse
66
Leukemia, Lymphocytic, Chronic, B-Cell
65
Lymphoma, Mantle-Cell
59
Lymphoma, Follicular
57
Neuroblastoma
44
Burkitt Lymphoma
44
Lymphoma, Large-Cell, Immunoblastic
40
Lymphoma, B-Cell, Marginal Zone
37
Recurrence
34
Myeloproliferative Disorders
32
Hematologic Neoplasms
32
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
30
Immunoglobulin Light-chain Amyloidosis
29
Leukemia, Myeloid, Accelerated Phase
25
Leukemia, Myeloid, Chronic-Phase
24
Congenital Abnormalities
24
Leukemia, Myelomonocytic, Chronic
23
Graft vs Host Disease
23
Dendritic Cell Sarcoma, Interdigitating
21
Waldenstrom Macroglobulinemia
20
Melanoma
20
Interventions
Morphine
7
Surveys and Questionnaires
6
Ketamine
5
Fentanyl
4
Sodium Chloride
3
Saline Solution
3
Lidocaine
3
Educational Status
3
Dexmedetomidine
3
Cognitive Behavioral Therapy
3
Anesthetics, Local
3
ziconotide
2
Pregabalin
2
Mindfulness-Based Stress Reduction
2
Hypnosis
2
Control Groups
2
Bupivacaine
2
Acetaminophen
2
6'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro(cyclohexane-1,1'(3'H)-pyrano(3,4-b)indol)-4-amine
2
tianeptine
1
siltuximab
1
onabotulinum toxin A
1
nabiximols
1
morphine, naltrexone combination
1
erenumab
1
Yoga
1
Waiting Lists
1
Transcutaneous Electric Nerve Stimulation
1
Tramadol
1
Therapeutics
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Chronic Pain
×
Melphalan
×
Clear all
NCT06154590
2023-12-04
NASBP-B-09
Paradyne Networks A Foundation
Not yet recruiting
100 enrolled